iSERA Lifesciences Ltd

NSE: COVIDH · BSE: 534920 · Software & Services · 20 announcements

Share price: ₹143.90
Market cap: ₹121.0 Cr
Revenue (annual): ₹1.36 Cr
Net profit (annual): ₹0.26 Cr
P/E (TTM): 466.5×Sector 21.8×
Promoter holding: 58.63%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 4 Other Announcement 3 Financial Results 3 Board Meeting Outcome 3 Board Meeting Date 2 Capital Structure Change 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

21 Apr 2026 15:31 IST BSE

Acquisition

Covidh Technologies Acquisition Worth ₹78 Cr

iSERA Lifesciences Limited approved the acquisition of a 100% stake in iSERA Biological Limited for ₹78 Crore via a 1:1 share swap. The transaction will be executed through a preferential allotment of 1,61,82,800 equity shares at ₹48.20 per share. Upon completion, iSERA Biological will become a wholly-owned subsidiary.

Value: ₹78.00 Cr
Execution: Within 15 days of shareholder or BSE approval

Read the filing ↗